Relay Therapeutics (RLAY) Operating Margin (QoQ) (2021 - 2026)

Relay Therapeutics (RLAY) Operating Margin (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Relay Therapeutics 3.31 Bn 3.31 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -175,352.00
Jun 30, 2025 -1.02 Mn
Mar 31, 2024 -922.05 Mn
Dec 31, 2023 921.99 Mn
Sep 30, 2023 8.88 Mn
Jun 30, 2023 -4.43 Mn
Mar 31, 2023 -1.60 Mn
Dec 31, 2022 -382,626.00
Sep 30, 2022 -365,052.00
Jun 30, 2022 -634,887.00
Mar 31, 2022 -302,512.00
Dec 31, 2021 -278,643.00
Sep 30, 2021 1.38 Mn
Jun 30, 2021 -1.85 Mn